American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2019
  • »
  • October

PANTHERX RARE: Named first national pharmacy holding an accredited distinction in rare disease

Press release submission | Oct 3, 2019
PANTHERx is proud to be the first pharmacy in the nation to be awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC).

PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). Read More »

AMNEAL PHARMACEUTICALS: MedicaSafe Announces Partnership with Amneal Pharmaceuticals

American Pharmacy News Reports | Oct 4, 2019

MedicaSafe will combine the generic version of Suboxone® (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence Read More »

ALLERGAN: Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA™ Lubricant Eye Drop Product Line

Press release submission | Oct 8, 2019

A Trifecta of Relief Formulated with HydroCell™ Technology Offers New Artificial Tear Options for Patients Suffering from Eye Dryness Read More »

SMP PHARMACY SOLUTIONS: Fastest Growing Fertility Pharmacy to Deliver Enhanced Services and Programs to West Coast Clinics

American Pharmacy News Reports | Oct 11, 2019

Florida-based SMP Pharmacy Solutions announces strategic acquisition of Northridge Plaza Pharmacy to serve growing demand in California fertility market Read More »

EYEVANCE PHARMACEUTICALS: Acquires TOBRADEX® ST and NATACYN®

Press release submission | Oct 16, 2019

Acquisition bolsters Eyevance's position as an emerging leader in treating anterior segment and ocular surface conditions Read More »

ADEMI & O'REILLY, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Alexion Pharmaceuticals, Inc.

American Pharmacy News Reports | Oct 17, 2019

Ademi & O'Reilly, LLP is investigating Achillion (NASDAQ:ACHN) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Achillion to Alexion. Read More »

BRYN PHARMA: Partners with Aptar Pharma for Nasal Epinephrine Treatment

Press release submission | Oct 24, 2019

Bryn's Epinephrine Nasal Spray has Two Doses in One Portable Device Read More »

CVS HEALTH: Expands Safe Medication Disposal Program in Wisconsin, Giving Customers Drug Disposal Options in All CVS Pharmacy Locations

American Pharmacy News Reports | Oct 24, 2019

Adding Drug Collection Units in 29 CVS Pharmacy Locations Across the State Read More »

CATALYST HEALTHCARE: CHC Health Partners with Catalyst Healthcare and Pack4U to Provide Virtual Pharmacist Services Targeting Medication Adherence Improvement

Press release submission | Oct 30, 2019

CHC Health has announced a strategic partnership with Catalyst Healthcare, an award-winning technology company, and Pack4U for delivery of connected care at home, to provide virtual pharmacist services for improving medication adherence and patient health outcomes. Read More »

CVS PHARMACY: Opens First Standalone Retail Locations in Oregon

American Pharmacy News Reports | Oct 31, 2019

Three new CVS Pharmacy stores to open in the Portland area by end of 2019, bringing a health-centric retail pharmacy experience to the market Read More »

Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up